tert-Butyl [(1-acetylpiperidin-4-yl)methyl]carbamate
![]() |
- $45 - $370
- Product name: tert-Butyl [(1-acetylpiperidin-4-yl)methyl]carbamate
- CAS: 1286273-14-0
- MF: C13H24N2O3
- MW: 256.34
- EINECS:
- MDL Number:MFCD18378205
- Synonyms:tert-Butyl [(1-acetylpiperidin-4-yl)methyl]carbamate;Tert-Butyl N-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate;Carbamic acid, N-[(1-acetyl-4-piperidinyl)methyl]-, 1,1-dimethylethyl ester
4 prices
Selected condition:
Brand
- Crysdot
- TRC
Package
- 10mg
- 50mg
- 100mg
- 1g
- ManufacturerCrysdot
- Product numberCD11300419
- Product descriptiontert-Butyl((1-acetylpiperidin-4-yl)methyl)carbamate 97%
- Packaging1g
- Price$370
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB862730
- Product descriptionTert-ButylN-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB862730
- Product descriptionTert-ButylN-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate
- Packaging50mg
- Price$155
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB862730
- Product descriptionTert-ButylN-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate
- Packaging100mg
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11300419 | tert-Butyl((1-acetylpiperidin-4-yl)methyl)carbamate 97% | 1g | $370 | 2021-12-16 | Buy |
TRC | B862730 | Tert-ButylN-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate | 10mg | $45 | 2021-12-16 | Buy |
TRC | B862730 | Tert-ButylN-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate | 50mg | $155 | 2021-12-16 | Buy |
TRC | B862730 | Tert-ButylN-[(1-Acetylpiperidin-4-Yl)Methyl]Carbamate | 100mg | $240 | 2021-12-16 | Buy |
Properties
Boiling point :406.6±18.0 °C(Predicted)
Density :1.047±0.06 g/cm3(Predicted)
pka :12.72±0.46(Predicted)
Density :1.047±0.06 g/cm3(Predicted)
pka :12.72±0.46(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|